Molecular Profiling of Druggable Targets in Clear Cell Renal Cell Carcinoma Through Targeted RNA Sequencing

Clear cell renal cell carcinoma (ccRCC) comprises more than 80% of all renal cancers and when metastasized leads to a 5-year survival rate of only 10%. The high rate of therapy failure and resistance development calls for reliable methods that provide information on the actionable biological pathway...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Heuvel, Corina N. A. M., van Ewijk, Anne, Zeelen, Carolien, de Bitter, Tessa, Huynen, Martijn, Mulders, Peter, Oosterwijk, Egbert, Leenders, William P. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407434/
https://www.ncbi.nlm.nih.gov/pubmed/30881919
http://dx.doi.org/10.3389/fonc.2019.00117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407434/
https://www.ncbi.nlm.nih.gov/pubmed/30881919
http://dx.doi.org/10.3389/fonc.2019.00117

Ejemplares similares